Cross-modal cerebellar stimulation to improve balance and vision in glaucoma
Official title: Cross-modal Neuromodulation to Improve Balance and Cognition in Older Adults With Glaucoma: A Randomized Trial of Cerebellar Transcranial Electrical Stimulation
Run by The Hong Kong Polytechnic University · NCT07771699 · Data updated 2026-11-12
In older adults with glaucoma, this study tests whether different cerebellar transcranial electrical stimulation methods can improve balance and visual-cognitive function.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 55 Years and up |
| Sex | All |
| Enrollment | 36 (estimated) |
| Sponsor | The Hong Kong Polytechnic University Academic / other |
| Locations | 1 site (Kowloon, Hong Kong) |
| Status | Recruiting |
| Started | July 1, 2026 |
| Main results expected | November 1, 2029 |
| Study ends | November 1, 2029 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT07771699 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 55 with open-angle or normal-tension glaucoma, measurable visual field loss, adequate daytime vision, preserved general cognition, and right-handedness.
✕Probably not a fit
Patients with additional ocular diseases, significant hearing impairment, or contraindications to transcranial electrical stimulation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, sham-controlled, cross-over trial will compare two cerebellar tES techniques (tDCS and tACS) against sham stimulation in adults over 55 with glaucoma. Participants receive 15 stimulation sessions across 3 blocks, with balance and visual-cognitive assessments before and after each session. The design aims to see if cerebellar stimulation produces longer-term improvements in balance and visual attention beyond short-term effects. The study leverages a within-subject approach to reduce variability and enhance detection of any treatment effects.
Why it matters
Potential benefit: If successful, patients could gain better balance and sharper visual-cognitive function, potentially lowering fall risk and improving daily activities.
How similar studies have gone: Previous research suggests cerebellar stimulation can influence balance; this study explores a novel, combined approach in glaucoma patients.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age over 55 years old; * Diagnosis of primary open-angle or normal-tension glaucoma with relative scotoma in both eyes; * Humphrey Field Analyzer visual field loss (mean deviation of ≤- 6 dB) using the 24-2 testing protocol for both eyes; * Best-corrected distance visual acuity of 6/12 (equivalent to 0.3 logMAR) or better; * Cognitive functional score of 22 or above in the Montreal Cognitive Assessment -Hong Kong version (HK-MoCA). * Only the right-handed population will be recruited (screening by the Edinburgh Handedness Inventory). Exclusion Criteria: * Have musculoskeletal disorders or neurological diseases that can affect the balance or nervous system. * Ocular diseases other than glaucoma (e.g., age-related macular degeneration, diabetic retinopathy, moderate to severe cataract) or severe hearing impairment (to ensure that participants can hear the instructions clearly during assessments and training) * Have any contraindications for tES
Where it's running
-
Hong Kong Polytechnic University
Kowloon, Hong Kong, Hong Kong Recruiting
Study contacts
- Principal investigator: Allen Ming yan Cheong, PhD — The Hong Kong Polytechnic University
- Study coordinator: Yihong PENG, Phd student
- Email: 22117438r@connect.polyu.hk
- Phone: +852-53937970
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Balance training for people with glaucoma
A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.
-
Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma
In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.
-
Comparison of FT-1000 non-contact tonometry with Goldmann applanation tonometry in glaucoma patients
This study tests whether the FT-1000 non-contact tonometer gives measurements that agree with the Goldmann applanation tonometer in adults with glaucoma.
-
Removing the ripcord from a glaucoma drainage device after 3 months
This study tests whether removing the ripcord from an implanted glaucoma drainage device changes eye pressure for adults with open-angle glaucoma.
-
Glaucoma and Brain Changes: How Brain Structure and Size See What Glaucoma Is Doing
This study tests whether glaucoma is linked to broader brain changes by comparing brain MRI and eye health over time in people with glaucoma and matched controls.
-
Long-Term Results After Ab-interno Trabeculotomy for Glaucoma
This study tests whether ab-interno trabeculotomy with the Trabectome can provide sustained intraocular pressure reduction in glaucoma patients who had the procedure between 2019 and 2021.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.